Rerouting therapeutic peptides and unlocking their potential against SARS-CoV2

Area of Science:

• Virology
• Immunology
• Drug Discovery
• Computational Biology

Background:

• The COVID-19 pandemic underscored the need for novel therapeutic strategies against SARS-CoV-2.
• Traditional pharmaceuticals face challenges in combating rapidly mutating viruses.
• Peptide-based therapies offer a potential alternative with diverse mechanisms of action.

Purpose of the Study:

• To review the role of therapeutic peptides in antiviral defense against SARS-CoV-2 and its variants.
• To explore peptide applications in immune modulation, viral entry inhibition, and replication disruption.
• To assess the potential of peptide therapies in future pandemic preparedness.

Main Methods:

• Literature review of existing research on peptide-based antiviral therapies.
• Analysis of studies focusing on peptide mechanisms against SARS-CoV-2.
• Exploration of advancements in computational modeling and artificial intelligence for peptide drug discovery.

Main Results:

• Therapeutic peptides demonstrate efficacy in modulating immune responses and inhibiting viral replication.
• Challenges include peptide stability, bioavailability, and viral mutation rates.
• Ongoing research and clinical trials indicate growing integration of peptide treatments.

Conclusions:

• Peptide-based therapies are a critical and promising component of future pandemic preparedness.
• AI and computational modeling will enhance peptide screening and repurposing strategies.
• Peptides offer a viable alternative or adjunct to traditional treatments for viral outbreaks.